DE60237213D1 - Hemmung der t-lymphozyten-aktivierung durch 3-deoxyflavonoide und relevante therapien - Google Patents
Hemmung der t-lymphozyten-aktivierung durch 3-deoxyflavonoide und relevante therapienInfo
- Publication number
- DE60237213D1 DE60237213D1 DE60237213T DE60237213T DE60237213D1 DE 60237213 D1 DE60237213 D1 DE 60237213D1 DE 60237213 T DE60237213 T DE 60237213T DE 60237213 T DE60237213 T DE 60237213T DE 60237213 D1 DE60237213 D1 DE 60237213D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- rutin
- deoxyflavonoids
- inhibition
- lymphocyte activation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31766601P | 2001-09-06 | 2001-09-06 | |
US40712502P | 2002-08-30 | 2002-08-30 | |
PCT/US2002/028348 WO2003022994A2 (en) | 2001-09-06 | 2002-09-06 | Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60237213D1 true DE60237213D1 (de) | 2010-09-16 |
Family
ID=26981074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60237213T Expired - Lifetime DE60237213D1 (de) | 2001-09-06 | 2002-09-06 | Hemmung der t-lymphozyten-aktivierung durch 3-deoxyflavonoide und relevante therapien |
Country Status (11)
Country | Link |
---|---|
US (2) | US6774142B2 (de) |
EP (1) | EP1429750B1 (de) |
JP (1) | JP2005504796A (de) |
KR (1) | KR20040048407A (de) |
CN (1) | CN1668287B (de) |
AT (1) | ATE476178T1 (de) |
AU (1) | AU2002332878A1 (de) |
BR (1) | BR0212354A (de) |
DE (1) | DE60237213D1 (de) |
MX (1) | MXPA04002077A (de) |
WO (1) | WO2003022994A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040102386A1 (en) * | 2001-09-06 | 2004-05-27 | Thomas Lahey | Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
DE10359384A1 (de) * | 2003-12-18 | 2005-07-28 | Anoxymer Gmbh | Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor |
EP1768675A4 (de) * | 2004-07-09 | 2008-03-12 | Medicure Int Inc | Kombinationstherapien mit nicotinsäure-derivaten oder fibrinsäurederivaten |
WO2006030322A2 (en) * | 2004-09-17 | 2006-03-23 | University Of Manitoba | Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions |
JP5380069B2 (ja) * | 2005-03-11 | 2014-01-08 | ハワード フローリー インスティチュート | フラボノイド化合物およびその使用 |
JPWO2006120974A1 (ja) * | 2005-05-06 | 2008-12-18 | 株式会社アミノアップ化学 | 軟骨代謝異常疾患改善用健康食品及び医薬品組成物 |
EP1951655A2 (de) * | 2005-11-17 | 2008-08-06 | Pfizer Limited | Aminosäurederivate |
KR100817662B1 (ko) | 2006-03-23 | 2008-03-27 | 주식회사 엘지생활건강 | c-Kit 활성 저해제, 피부미백제 및 이를 함유하는피부미백용 조성물 |
JP2009528273A (ja) * | 2006-01-25 | 2009-08-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連使用用の置換ビアリール化合物 |
EP1983971A4 (de) * | 2006-01-25 | 2010-11-24 | Synta Pharmaceuticals Corp | Substituierte aromatische verbindungen für entzündungs- und immunbedingte verwendung |
AU2008282273A1 (en) * | 2007-07-31 | 2009-02-05 | Limerick Biopharma, Inc. | Pyrone analog compositions and methods |
US7947733B2 (en) * | 2007-07-31 | 2011-05-24 | Limerick Biopharma | Phosphorylated pyrone analogs and methods |
GB0805312D0 (en) * | 2008-03-20 | 2008-04-30 | Medical Res Council | Modulation of the immune response |
CN102215841A (zh) * | 2008-08-29 | 2011-10-12 | 诺沃根研究控股有限公司 | 免疫调节活性 |
JP2012505251A (ja) * | 2008-10-10 | 2012-03-01 | リメリック バイオファーマ, インコーポレイテッド | 代謝性疾患の処置のためのピロン |
EP2424541A2 (de) * | 2009-04-27 | 2012-03-07 | Limerick BioPharma, Inc. | Phosphorylierte und phosphonierte pyron-analoga zur therapeutischen behandlung |
JP5594719B2 (ja) * | 2010-01-06 | 2014-09-24 | 国立大学法人神戸大学 | 筋肉の糖取り込み促進剤 |
CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
JP2014524426A (ja) * | 2011-08-12 | 2014-09-22 | ソーク インスティテュート フォー バイオロジカル スタディーズ | 神経保護ポリフェノールアナログ |
CN102872155B (zh) * | 2012-10-30 | 2014-04-02 | 中国人民解放军第四军医大学 | 一种黄酮苷类化合物在制备治疗脑中风药物中的应用 |
KR101497935B1 (ko) * | 2013-04-19 | 2015-03-03 | 경북대학교 산학협력단 | 루테올린을 유효성분으로 포함하는 섬유증의 예방 또는 치료용 조성물 |
EP2894200A1 (de) * | 2014-01-13 | 2015-07-15 | Rubia Exploitatie B.V. | Verfahren zur Herstellung einer Farbstoffpräparation |
CN104387360B (zh) * | 2014-11-21 | 2016-10-05 | 潍坊医学院 | 柚皮素脂肪酸酯、其制备方法和以该化合物为活性成分的药物组合物及其应用 |
CA2974123C (en) | 2015-02-02 | 2023-08-01 | Mei Pharma, Inc. | Combination of benzopyran derivative and glycolytic inhibitors for cancer therapy |
CA2985013C (fr) * | 2015-05-21 | 2024-04-16 | Ophtalmis Monaco | Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur |
CN108395461B (zh) * | 2017-02-07 | 2022-01-07 | 浙江康恩贝制药股份有限公司 | 7,4′-O-β-D-葡萄糖桑色素苷及其制备和其在制备抗炎药物中的应用 |
GB201811312D0 (en) * | 2018-07-10 | 2018-08-29 | Nuchido Ltd | Compositions |
CN109265424B (zh) * | 2018-09-25 | 2020-08-21 | 天津中医药大学 | 一种黄酮类衍生物及其制备方法和鉴定方法 |
CN109620771B (zh) * | 2018-12-19 | 2022-08-26 | 浙江奥比特生物科技有限公司 | 一种肌肤抗炎祛痘的化妆品组合物及其产品 |
CN110642825B (zh) * | 2019-10-16 | 2021-06-15 | 中国海洋大学 | 一种黄酮类衍生物及其制备方法和在制备免疫增强剂中的应用 |
CN111978330B (zh) * | 2020-09-03 | 2023-08-22 | 中国科学院昆明植物研究所 | 黄烷醇-脂肪醇杂合体及其药物组合物与其制备方法和应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867541A (en) * | 1972-05-03 | 1975-02-18 | Ralph C Robbins | Compositions and methods for disaggregating blood cells |
JPS5899414A (ja) * | 1981-12-10 | 1983-06-13 | Jun Okuda | アルド−スレダクタ−ゼの阻害剤 |
JP2544734B2 (ja) * | 1987-03-24 | 1996-10-16 | コスモ開発株式会社 | 免疫抑制剤 |
JPH03232851A (ja) * | 1989-12-26 | 1991-10-16 | Nippon Flour Mills Co Ltd | アルドース還元酵素阻害剤 |
WO1997032872A1 (en) * | 1996-03-05 | 1997-09-12 | Imperial College Of Science Technology And Medicine | Compounds with a sulfamate group |
JPH05286962A (ja) * | 1992-02-14 | 1993-11-02 | Kyowa Hakko Kogyo Co Ltd | 5−アミノフラボン誘導体 |
JPH08104628A (ja) * | 1994-10-04 | 1996-04-23 | Sumitomo Pharmaceut Co Ltd | マトリックスメタロプロテアーゼ阻害剤 |
DE69620514T2 (de) * | 1995-02-06 | 2002-11-28 | Kyowa Hakko Kogyo Kk | 5-aminoflavon-derivate |
JPH09176010A (ja) * | 1995-12-27 | 1997-07-08 | Kureha Chem Ind Co Ltd | Hsp60ファミリーに属するタンパク質のフラボノイド含有合成抑制剤 |
JPH09176011A (ja) * | 1995-12-27 | 1997-07-08 | Kureha Chem Ind Co Ltd | Hsp27ファミリーに属するタンパク質のフラボノイド含有合成抑制剤 |
US6506792B1 (en) * | 1997-03-04 | 2003-01-14 | Sterix Limited | Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using |
AU5531599A (en) * | 1998-09-01 | 2000-03-21 | Lg Chemical Ltd. | Novel cdk inhibitors having flavone structure |
KR20000019716A (ko) * | 1998-09-15 | 2000-04-15 | 박호군 | 바이오플라보노이드 화합물을 포함하는 혈당 강하용 조성물 |
JP2002541116A (ja) * | 1999-04-05 | 2002-12-03 | ジーグラー,ランディー,エイチ | 糖尿病の治療のための組成物及び方法 |
WO2001021608A2 (en) * | 1999-09-23 | 2001-03-29 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Novel flavonoids |
US6334998B1 (en) * | 1999-12-07 | 2002-01-01 | Parker Hughes Institute | Estrogens for treating ALS |
EP1127572A3 (de) * | 2000-02-25 | 2003-05-02 | Basf Aktiengesellschaft | Verwendung von Flavonen zur Behandlung von Cyclooxygenase-2 ermittelten Krankheiten |
JP2002010753A (ja) * | 2000-04-24 | 2002-01-15 | Marukin Chuyu Co Ltd | オリーブ葉またはその抽出成分を含有するアミラーゼ阻害剤および高血糖者用食品 |
-
2002
- 2002-09-06 JP JP2003527059A patent/JP2005504796A/ja active Pending
- 2002-09-06 AU AU2002332878A patent/AU2002332878A1/en not_active Abandoned
- 2002-09-06 WO PCT/US2002/028348 patent/WO2003022994A2/en active Application Filing
- 2002-09-06 DE DE60237213T patent/DE60237213D1/de not_active Expired - Lifetime
- 2002-09-06 US US10/236,861 patent/US6774142B2/en not_active Expired - Lifetime
- 2002-09-06 AT AT02798140T patent/ATE476178T1/de not_active IP Right Cessation
- 2002-09-06 EP EP02798140A patent/EP1429750B1/de not_active Expired - Lifetime
- 2002-09-06 KR KR10-2004-7003414A patent/KR20040048407A/ko not_active Application Discontinuation
- 2002-09-06 CN CN028204700A patent/CN1668287B/zh not_active Expired - Fee Related
- 2002-09-06 BR BR0212354-1A patent/BR0212354A/pt not_active IP Right Cessation
- 2002-09-06 MX MXPA04002077A patent/MXPA04002077A/es not_active Application Discontinuation
-
2004
- 2004-05-04 US US10/838,766 patent/US20040209825A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0212354A (pt) | 2004-11-30 |
EP1429750A2 (de) | 2004-06-23 |
US20040209825A1 (en) | 2004-10-21 |
MXPA04002077A (es) | 2005-02-17 |
US6774142B2 (en) | 2004-08-10 |
WO2003022994A2 (en) | 2003-03-20 |
US20030069192A1 (en) | 2003-04-10 |
EP1429750A4 (de) | 2005-08-03 |
CN1668287A (zh) | 2005-09-14 |
KR20040048407A (ko) | 2004-06-09 |
ATE476178T1 (de) | 2010-08-15 |
CN1668287B (zh) | 2012-03-28 |
JP2005504796A (ja) | 2005-02-17 |
AU2002332878A1 (en) | 2003-03-24 |
EP1429750B1 (de) | 2010-08-04 |
WO2003022994A3 (en) | 2003-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE476178T1 (de) | Hemmung der t-lymphozyten-aktivierung durch 3- deoxyflavonoide und relevante therapien | |
TW200612934A (en) | Quaternary salt CCR2 antagonists | |
SG91925A1 (en) | Post treatment of via opening by n-containing plasma or h-containing plasma for elimination of fluorine species in the fsg near the surfaces of the via opening | |
DE602006015928D1 (de) | Acylierte glp-1 verbindungen | |
GB2393983B (en) | Alternative path multilateral production/injection | |
NO20020792L (no) | Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid | |
CY1110405T1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
DE60022152D1 (de) | Parallele optimierte Ereignisauslösung in parallelen Datenbanksystemen | |
DE602004019855D1 (de) | Sicherheitsüberwacher für einen am Telefon angebrachten Hilfsrechner | |
WO2007005625A3 (en) | Systems and methods for synchronizing music | |
TNSN05197A1 (en) | Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation -and immunologically- mediated diseases | |
DE602005003404D1 (de) | Brechhammer und Befestigungselement, Seitenplatte und Schutzgehäuse des Brechhammers | |
SG148198A1 (en) | Methods and reagents for the treatment of inflammatory disorders | |
CY1107739T1 (el) | Ανταγωνιστες υποδοχεων οπιοειδων σε διαδερματικα συστηματα με μπουπρενορφινη | |
DE69830241D1 (de) | Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen | |
FR2898222B1 (fr) | Dispositif de commande electrique | |
ATE295928T1 (de) | Gleitschienentürschliesser | |
EP1736472A4 (de) | 2-aminopyridinderivat | |
MXPA06000507A (es) | Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiovasculares. | |
TR200100240T2 (tr) | Anksiyete bozukluklarının tedavisi | |
ATE473970T1 (de) | N-substituiertes benzothiophensulfonamidderivat | |
FR2835436B1 (fr) | Instrumentation pour analgesie, notamment peridurale | |
TR200402036T4 (tr) | (-)-Cis-2-(2-Klorofenil)-5, 7-Dihidroksi-8-[4R-(3S-Hidroksi-1-Metil) Piperidinil]-4H-1- Benzopiran-4-on'un psödopolimorfu | |
ITBG20020028A1 (it) | Struttura di armadio per quadri elettrici. | |
FR2866980B1 (fr) | Dispositif electrique de securite d'une serrure de porte, notamment de porte d'ascenseur |